Quantitative metabolomics services for biomarker discovery and validation.
Specializing in ready to use metabolomics kits.
Your source for quantitative metabolomics technologies and bioinformatics.
Loader

Filter by Species:

Filter by Pathway Type:

Select Pathway Sub-Category:

Select Pathway Sub-Category:


Search for '28cortisol oh aldosterone 20 and subjected 3ametabolic' in 'all pathways' in 'all' returned 511009 results

SMP0120608

Pw121864 View Pathway
Metabolite

Long-Chain-3-Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHAD)

Mus musculus

  • Matched Description: mitochondrial beta-oxidation of long chain fatty acids. HADHA converts medium- and long-chain 2-enoyl-CoA … compounds into the corresponding 3-ketoacyl-CoA compounds when NAD is present, and acetyl-CoA when … NAD and CoASH are present. Deficiencies in this enzyme prevent the body from converting certain fats … to energy, particularly during periods without food (fasting). Signs and symptoms of LCHAD … deficiency typically manifest during infancy or early childhood and can include feeding difficulties

  • Disease

    SMP0125016

    Pw126547 View Pathway
    Metabolite

    Hydrocodone Opioid Agonist Action Pathway

    Homo sapiens

  • Matched Description: Hydrocodone is an opioid agonist used as an analgesic and antitussive agent. It is a synthetic … and allergic rhinitis in combination with decongestants, antihistamines, and expectorants … . Hydrocodone inhibits pain signaling in both the spinal cord and brain. Its actions in the brain also produce … euphoria, respiratory depression, and sedation. Hydrocodone binds to mu opioid receptors … and cAMP located at the inner surface of the plasma membrane, opioids decrease intracellular cAMP

  • Drug Action

    SMP0120827

    Pw122088 View Pathway
    Metabolite

    Long-Chain-3-Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHAD)

    Rattus norvegicus

  • Matched Description: mitochondrial beta-oxidation of long chain fatty acids. HADHA converts medium- and long-chain 2-enoyl-CoA … compounds into the corresponding 3-ketoacyl-CoA compounds when NAD is present, and acetyl-CoA when … NAD and CoASH are present. Deficiencies in this enzyme prevent the body from converting certain fats … to energy, particularly during periods without food (fasting). Signs and symptoms of LCHAD … deficiency typically manifest during infancy or early childhood and can include feeding difficulties

  • Disease

    SMP0125954

    Pw127526 View Pathway
    Metabolite

    Paritaprevir Action Pathway

    Homo sapiens

  • Matched Description: target hepatocytes via receptor-mediated endocytosis. The lipoviroparticles attach to LDL-R and SR-B1 … , and then the virus binds to CD81 and subsequently claudin-1 and occludin, which mediate the late … the mature Hepatitis C virion and translated at the rough endoplasmic reticulum into a single … generates nonstructural proteins NS3, NS4A, NS4B, NS5A, and NS5B. These proteins are required in … concentration above their antiviral half-maximal effective concentration (EC50), Paritaprevir and other

  • Drug Action

    SMP0126320

    Pw127913 View Pathway
    Metabolite

    Lacidipine Action Pathway

    Homo sapiens

  • Matched Description: antihypertensive agent to dilate peripheral arterioles and reduce blood pressure. Lacidipine is a specific … and potent calcium antagonist with a predominant selectivity for calcium channels in the vascular … smooth muscle. Its main action is to dilate predominantly peripheral and coronary arteries, reducing … peripheral vascular resistance and lowering blood pressure. By blocking the voltage-dependent L-type … calcium ultimately causes the excitation and depolarization of the tissues. Lacidipine inhibits the

  • Drug Action

    SMP0126463

    Pw128062 View Pathway
    Metabolite

    Prasugrel Action Pathway

    Homo sapiens

  • Matched Description: bloodstream and acts on the P2Y12 receptor in platelets. By irreversibly binding to the P2Y12 receptors it … impairs ADP mediated activation of glycoprotein GPIIb/IIIa complex. Due to the anticoagulant and … antiplatelet activity, it is recommended to avoid herbs and supplements with similar activity such as … garlic, ginger, bilberry, danshen, piracetam and ginkgo biloba.

  • Drug Action

    SMP0646163

    Pw686508 View Pathway
    Metabolite

    Pyrimidine Deoxyribonucleosides Degradation

    Odoribacter splanchnicus DSM 20712

  • Matched Description: and a deoxycytidien deaminsa resultin in the release of a ammonium and a a deoxyuridine. The … -phosphate and a uracil. The degradation of thymidine starts with thymidine being introduced into the … resulting in the release of a thymine and a deoxyribose 1-phosphate.

  • Metabolic

    SMP0498600

    Pw523809 View Pathway
    Metabolite

    Pyrimidine Deoxyribonucleosides Degradation

    Methylococcus capsulatus

  • Matched Description: and a deoxycytidien deaminsa resultin in the release of a ammonium and a a deoxyuridine. The … -phosphate and a uracil. The degradation of thymidine starts with thymidine being introduced into the … resulting in the release of a thymine and a deoxyribose 1-phosphate.

  • Metabolic

    SMP0497994

    Pw523099 View Pathway
    Metabolite

    Pyrimidine Deoxyribonucleosides Degradation

    Bacteroides clarus YIT 12056

  • Matched Description: and a deoxycytidien deaminsa resultin in the release of a ammonium and a a deoxyuridine. The … -phosphate and a uracil. The degradation of thymidine starts with thymidine being introduced into the … resulting in the release of a thymine and a deoxyribose 1-phosphate.

  • Metabolic

    SMP0483825

    Pw506451 View Pathway
    Metabolite

    Citrate Lyase Activation

    Escherichia coli (strain 55989 / EAEC)

  • Matched Description: The citrate lyase activation starts with a 3-dephospho-CoA reacting with ATP and a hydrogen ion … through a triphosphoribosyl-dephospho-CoA synthase resulting in a adenine and a 2'-(5'-triphospho … release of a pyrophosphate and a hydrogen ion and a holo citrate lyase acyl-carrier protein.This … protein complex can either react with a hydrogen ion and a acetate resulting in the release of a water … and an acetyl-holo citrate lyase acyl-carrier protein. The holo acyl-carrier protein creacts with an

  • Metabolic